We aimed to evaluate the subclinical left ventricular (LV) systolic dysfunction with the automated function imaging method (AFI) based on speckle tracking echocardiography (STE) in obstructive sleep apnea patients (OSA) with normal left ventricular ejection fraction (LVEF) and without any confounding disease that can cause myocardial dysfunction. Twenty-one healthy individuals and 58 OSA patients were included in this observational cross-sectional study. According to the severity of disease, OSA patients were examined in three groups; mild, moderate and severe OSA. Apical 2-, 3- and 4- chamber images were obtained for AFI evaluation. The global systolic longitudinal strain (GLS) values were determined for each view, and averages of these were used in comparison of the patient groups. One-way ANOVA, Kruskal-Wallis, Pearson correlation tests and linear regression analysis were used for statistical analysis. The GLS values of the OSA patients were lower than of the healthy individuals and these values were decreased along with the OSA severity (Healthy:-25.58±-2.16%, Mild:-23.93±-3.96%, Moderate:-21.27±-2.60%, Severe:-16.94±-2.66%, respectively). The difference was significant between moderate OSA patients and healthy individuals, and significant between severe OSA patients and all other groups (p<0.03). The apnea-hypopnea index was found to be correlated with the GLS (β=-0.659, 95% CI: 0.09-0.17, p<0.001). Longitudinal LV mechanics in OSA patients with normal LVEF are deteriorated in the subclinical stage being associated with the severity of disease. AFI can be used as an effective and safe method in the determination of subclinical myocardial dysfunction in OSA patients, because it is semi-automated and easy to use with a short analysis time.
1 January 2017 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Although the definition of polypharmacy is not yet clear today, it is generally regarded as drug use more than the patient needs. Advanced age is the most important risk factor for polypharmacy. In addition, other risk factors are loss of current cognitive functions, low socioeconomic level and nursing care. It is seen in about 40% of people over 75 years of age worldwide, varying between countries of extreme poverty. Incorrect drug use, drug side effects and drug-drug interaction lead to unwanted hospitalizations. In particular, cardiovascular drugs pose risks in terms of drug side effects in advanced ages. Altering the pharmacokinetics and pharmacodynamics of the drug along with advanced age lead to more frequent side effects or no effect of the drugs. The most important point to prevent polypharmacy is to inform the patient or the patient's caregiver fully and to target treatment with a minimum number of drugs and doses.
31 December 2024 in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
Aim: As no study has compared perioperative 5-Fluorouracil (5-FU), oxaliplatin, and docetaxel (FLOT) chemotherapy regimens with postoperative adjuvant oral capecitabine and oxaliplatin/5-FU and oxaliplatin (CAPEOX/FOLFOX) chemotherapy regimens, the goal of this study was to compare them in terms of median and overall survival of operable gastric cancers. Methods: This single-center, retrospective study recruited 59 subjects (17 females and 42 males) with at least T2 or more invasive gastric cancers with or without positive lymph node(s). All the patients underwent total or subtotal ((sub) total) gastric resection with D2 lymph node dissection. The Statistical Package for the Social Sciences (IBM SPSS) 26.0 program was used to statistically analyze the research findings. Results: The peri-operative FLOT treatment group with 30 patients displayed significantly more advanced clinical nodal (cN) stage (p
1 April 2026 in Journal of Clinical and Analytical Medicine
Aim The goal of this study was to find out easily applicable laboratory parameters to predict the response and outcome of patients receiving immunotherapy treatments in routine oncology clinics. Methods Patients who were followed up in the oncology outpatient clinic, diagnosed with CA, and received immunotherapy were included in this study. Demographic, diagnostic, laboratory, pathology, treatment, and duration of ımmunotherapy response data were extracted from the medical history of patients, radiological assessments, and pathology reports in both patient files and electronic records. The obtained data were analyzed in the SPSS program, and the significance level was taken as P < .05. Results This study recruited 80 patients, 21 females and 59 males, diagnosed with advanced-stage solid tumors treated with immunotherapy with or without chemotherapy. Statistically significant longer median response duration in patients with serum CRP level <10 mg/L was detected when compared to patients with higher CRP ≥10 mg/L (372 and 227 days, respectively, P = .001). Moreover, there was a statistically significant difference between serum albumin and monocyte levels of patients with CRP level <10 mg/L and patients with CRP ≥10 mg/L in terms of immunotherapy response duration (P = .001 and 0.017, respectively). Peripheral blood albumin < 4mg/dl and monocyte >0.6x103L were related to decreased duration of response to immunotherapies. Conclusion Routine peripheral blood C-reactive protein, albumin, and monocyte levels may predict who will get more benefit from novel immunotherapeutic agents.